Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Beckman Coulter Access Anti-HCV Assay as an Aid in the Diagnosis of HCV Infection: EU Clinical Trial Protocol

NCT04971330 is registered in ClinicalTrials.gov with Beckman Coulter, Inc. as lead sponsor.

NCT NCT04971330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04971330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Beckman Coulter Access Anti-HCV Assay as an Aid in the Diagnosis of HCV Infection: EU Clinical Trial Protocol
Lead sponsor
Beckman Coulter, Inc.
Phase
Observational
Overall status
Completed
Start date
November 4, 2019
Completion date
March 30, 2021
Enrollment
7,901 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hcv